Fred Andy Broadway III

2017

In 2017, Fred Andy Broadway III earned a total compensation of $683.5K as President, BioTel Heart at BioTelemetry, a 9% increase compared to previous year.

Compensation breakdown

Non-Equity Incentive Plan$189,375
Option Awards$93,827
Salary$301,981
Stock Awards$87,310
Other$11,002
Total$683,495

Broadway received $302K in salary, accounting for 44% of the total pay in 2017.

Broadway also received $189.4K in non-equity incentive plan, $93.8K in option awards, $87.3K in stock awards and $11K in other compensation.

Rankings

In 2017, Fred Andy Broadway III's compensation ranked 10,715th out of 14,666 executives tracked by ExecPay. In other words, Broadway earned more than 26.9% of executives.

ClassificationRankingPercentile
All
10,715
out of 14,666
27th
Division
Services
1,828
out of 2,424
25th
Major group
Health Services
186
out of 224
17th
Industry group
Miscellaneous Health And Allied Services, Not
27
out of 34
21st
Industry
Specialty Outpatient Facilities, Not Elsewhere Classified
13
out of 13
0th
Source: SEC filing on March 22, 2018.

Broadway's colleagues

We found four more compensation records of executives who worked with Fred Andy Broadway III at BioTelemetry in 2017.

2017

Joseph Capper

BioTelemetry

Chief Executive Officer

2017

Heather Getz

BioTelemetry

Chief Financial Officer

2017

Daniel Wisniewski

BioTelemetry

Senior Vice President, Technical Operations

2017

Peter Ferola

BioTelemetry

General Counsel

News

You may also like